You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 125 No. 2, February 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Implications of Dietary Oils and Polyunsaturated Fatty Acids in the Management of Cutaneous Disorders

Vincent A. Ziboh, PhD

Arch Dermatol. 1989;125(2):241-245.


Abstract

• A major proinflammatory metabolite of arachidonic acid, leukotriene B4, is known to accumulate in the lesions of psoriasis. Most of this metabolite is biosynthesized by the polymorphonuclear cells that infiltrate into the psoriatic lesions. Epidermal 15-lipoxygenase, on the other hand, metabolizes arachidonic acid into 15-hydroxyeicosatetraenoic acid (15-20:4n-6), presumably serving as a negative feedback to inhibit the local generation of leukotriene B4-Eicosapentaenoic acid, a major polyunsaturated fatty acid in fish oil, and {gamma}-linolenic acid, a poly-unsaturated fatty acid in certain vegetable oils, are both metabolized by epidermal 15-lipoxygenase into 15-hydroxyeicosapentaenoic acid (15-OH-20:5n-3) and 15-hydroxyeicosatriaenoic acid (15-OH-20:3n-3), respectively. Both of these monohydroxy acids are potent in vitro inhibitors of leukotriene B4 generation. It seems reasonable, therefore, that adequate dietary supplementation with eicosapentaenoic acid or {gamma}-linolenic acid may offer a novel and nontoxic approach to suppressing cutaneous inflammatory disorders.

(Arch Dermatol 1989;125:241-245)



Author Affiliations

From the Department of Dermatology, School of Medicine, University of California at Davis.


Footnotes

Accepted for publication July 29, 1988.

Read before the Festschrift and Celebration for Harvey Blank, MD, University of Miami, Feb 19-20, 1988.

Reprint requests to Department of Dermatology, TB 192, School of Medicine, University of California at Davis, Davis, CA 95616 (Dr Ziboh).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Nutritional skin care: health effects of micronutrients and fatty acids
Boelsma et al.
Am. J. Clin. Nutr. 2001;73:853-864.
ABSTRACT | FULL TEXT  

Essential fatty acid metabolism and its modification in atopic eczema1
Horrobin
Am. J. Clin. Nutr. 2000;71:367S-372S.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.